Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy Barclays PLC

Start price
€771.40
31.10.24 / 50%
Target price
€896.61
31.10.25
Performance (%)
-3.29%
End price
€746.00
01.11.25
Summary
This prediction ended on 01.11.25 with a price of €746.00. With a performance of -3.29%, the BUY prediction for Eli Lilly Corp. by Barclays_PLC closed slightly in the red. Dividends of €2.66 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Eli Lilly Corp. 0.922% 0.922% 17.157%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Barclays_PLC for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) -3.29%
Target price 896.610
Change
Ends at 31.10.25

Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Barclays PLC from $1,025.00 to $975.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat

In the thread Trading Eli Lilly Corp.
Prediction Buy
Perf. (%) -3.29%
Target price 896.610
Change
Ends at 31.10.25

Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Barclays_PLC for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€859.00
11.07.24
€941.16
11.07.25
-21.42%
12.07.25

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€676.00
07.02.24
€751.76
07.02.25
26.20%
08.02.25

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€580.50
23.01.24
€625.12
23.01.25
25.75%
24.01.25